A Crucial Role for Dendritic Cell (DC) IL-10 in Inhibiting Successful DC-Based Immunotherapy: Superior Antitumor Immunity Against Hepatocellular Carcinoma Evoked by DC Devoid of IL-10

Journal of Immunology - United States
doi 10.4049/jimmunol.179.9.6009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

IL-1 Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation

Journal of Immunology
AllergyImmunology
2002English

Role of IL-10 in Urinary Bladder Carcinoma and Bacillus Calmette-Guerin Immunotherapy

American Journal of Immunology
AllergyImmunology
2012English

Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10

Frontiers in Immunology
AllergyImmunology
2014English

Optimized Dendritic Cell (DC) Vaccine Regimen

Science-Business eXchange
2011English

Human Tolerogenic DC-10: Perspectives for Clinical Applications

Transplantation Research
TransplantationImmunology
2012English

Dab2, a Negative Regulator of DC Immunogenicity, Is an Attractive Molecular Target for DC-based Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2015English

Virotherapy-Recruited PMN-MDSC Infiltration of Mesothelioma Blocks Antitumor CTL by IL-10-mediated Dendritic Cell Suppression

OncoImmunology
OncologyAllergyImmunology
2018English

Comparison of SiC-based DC-DC Modular Converters for EV Fast DC Chargers

2019English

Soft Switched Voltage Multiplier Cell Based DC-DC Converter for Automotive Applications

Automatika
ControlSystems EngineeringComputer Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy